Who published this market news?

TradingView published this market news item.

Cadrenal Therapeutics' James J. Ferguson III to Resign as Chief Medical Officer

Cadrenal Therapeutics' Chief Medical Officer James J. Ferguson III will resign effective July 31, 2026.Original SEC Filing: Cadrenal Therapeutics, Inc. [ CVKD ] - 8-K - Jul. 10, 2026This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source…

Cadrenal Therapeutics' Chief Medical Officer James J. Ferguson III will resign effective July 31, 2026.

IndividualJames J. Ferguson III

RoleChief Medical Officer

Type of ChangeResignation

Effective DateJuly 31, 2026

ReasonNot disclosed

Replacement InfoCompany conducting search for replacement

Background DetailsNot disclosed

Board/Committee Role ChangesNot disclosed

Original SEC Filing:

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.